In the global race to develop the most effective Covid-19 vaccine, Pfizer and BioNTech are determined to establish their position as top candidate.
Phase 3 results involving 43,000 participants have concluded that the Pfizer and BioNTech vaccine is 95% effective within 28 days of the first dose.
The duo also addressed the issue of temperature requirements regarding vaccine transportation, stating that they have “developed specially designed, temperature-controlled thermal shippers utilizing dry ice to maintain temperature conditions of -70°C±10°C”.
